Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Alliance Hill Day Tops 60 Meetings Read More Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 6/15/18 Advocacy at a Glance STEVEN GROSSMAN 6/15/18 House Passes First Mini-bus; Won’t Consider Next Until Committee Acts on All 12 Bills Read More Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Appropriations Process: Pace is Uncertain When Congress Returns Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More
Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Alliance Hill Day Tops 60 Meetings Read More
Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More
STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 6/15/18 Advocacy at a Glance STEVEN GROSSMAN 6/15/18 House Passes First Mini-bus; Won’t Consider Next Until Committee Acts on All 12 Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Appropriations Process: Pace is Uncertain When Congress Returns Read More
